Unity Biotechnology, Inc. Gains 54.1%
Fri, Aug 12, 2022 at 07:07 PM
Unity Biotechnology, Inc. (UBX:NASDAQ) shot up at $1.31, a gain of 54.1%. On Fri, Aug 12, 2022, UBX:NASDAQ touched a New 2-Week High of $1.31. The stock appeared on our News Catalysts scanner on Fri, Aug 12, 2022 at 12:39 PM in the 'BIOTECH' category. From Fri, Jul 29, 2022, the stock recorded 60.00% Up Days and 54.55% Green Days
The stock spiked on Fri, Aug 12, 2022 at $1.85 with a volume of 93M+.
About Unity Biotechnology, Inc. (UBX:NASDAQ)
Unity Biotechnology Inc operates as a biotechnology company. The firm focuses on age-associated diseases such as arthritis, vision loss and cognitive decline.
Top 10 Gainers:
- Embark Technology Inc. (EMBK:NASDAQ), 84.8%
- Twin Vee PowerCats Co. (VEEE:NASDAQ), 77.5%
- AN2 Therapeutics Inc. (ANTX:NASDAQ), 64.66%
- Unity Biotechnology, Inc. (UBX:NASDAQ), 54.1%
- Conifer Holdings, Inc. (CNFR:NASDAQ), 46.18%
- GoHealth Inc. (GOCO:NASDAQ), 41.78%
- Everspin Technologies, Inc. (MRAM:NASDAQ), 39.69%
- Rani Therapeutics Holdings Inc. (RANI:NASDAQ), 37.55%
- ADDvantage Technologies Group, Inc. (AEY:NASDAQ), 35.46%
- Berkshire Grey Inc. (BGRY:NASDAQ), 31.65%